Have you thought about what kind of impact the Homeland Investment Act (HIA) could have on small biotech companies like GENR (if the passed it into law.) Large-cap Pharma (BOL, MRK, SGP, JNJ, LLY) have been the biggest supporters of the Act and should be some of the largest beneficiaries of the Act. IMO, the passing of the Act will increase the number of lucrative big-pharma partnership deals in the upcoming tax year.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.